Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on July 8, 2026 by admin

An AAV vector for glial cells

Nature Biotechnology, Published online: 08 July 2026; doi:10.1038/s41587-026-03193-2

Delivery of an in vivo–selected AAV into the glymphatics achieves broad transduction of human glial cells in chimeric mice.

CategoriesUncategorized TagsBiotech, News Approved

Post navigation

Previous PostPrevious Efficient targeting of human glial progenitor cells in vivo with engineered AAV vectors and glymphatic delivery
Next PostNext Parental broad autism phenotype traits and executive function in families of children with autism spectrum disorder
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.